Goldman Sachs analyst Asad Haider says investors are overreacting to the late-stage data Eli Lilly & Co (NYSE: LLY) reported for its experimental oral obesity pill, orforglipron, on Thursday.Lilly reported blockbuster results for the second quarter and raised its full-year guidance on August 7th.Still, the healthcare stock tumbled after management…
The FTSE 100 Index pulled back this week as many British companies like Intercontinental Hotels, Legal & General, BP,…
Asian stock markets rose on Friday, with a powerful rally in Japanese shares leading the way, as investors reacted…
India’s domestic institutional investors stepped in with their largest purchase of local stocks in four months on Thursday, providing…
European stock markets began Friday’s session with a mixed and somewhat hesitant performance, as a sharp drop in shares…
Novo Nordisk shares rose over 5% in morning trade on Friday, ranking among the top gainers on the STOXX…
Global food commodity prices reached a two-year high in July, primarily due to increased international prices for meat and…
The Vanguard S&P 500 ETF (VOO) remained in a tight range this week as investor sentiment weakened and as…
Asian equities closed mostly lower on Friday as US President Donald Trump’s sweeping reciprocal tariffs against more than 90…